Home › Funds › DCF Advisers, LLC › CRVS

DCF Advisers, LLC position in CRVS

CORVUS PHARMACEUTICALS INC · Health Care

DCF Advisers, LLC reported holding 641,500 shares of CRVS (CORVUS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$7.4M, representing 2.18% of its reported portfolio and ranking #11 among its reported holdings. DCF Advisers, LLC has disclosed CRVS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)641.50K sh
Reported value held$7.39M
Portfolio Weight2.18%
First reportedQ4 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How DCF Advisers, LLC's CRVS position evolved

DCF Advisers, LLC first disclosed a stake in CRVS in Q4 2024 at 28,681 shares (US$153K). The position peaked in Q2 2026 at 637,500 shares, worth US$9.5M. Across 8 filings, DCF Advisers, LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 641,500 shares valued at US$7.4M — an increase of 4,000 shares quarter over quarter.. Notable position changes include a 83% trim in Q1 2025 (shares rose 26% over the following quarter), a 50% trim in Q2 2025 (shares rose 84% over the following quarter), a 30640% increase in Q3 2025 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 28.68K $153.44K New
Q1 2025 5.00K $15.90K Reduce
Q2 2025 2.50K $10.00K Reduce
Q3 2025 768.50K $5.66M Add
Q4 2025 729.00K $5.61M Reduce
Q1 2026 637.50K $9.33M Reduce
Q2 2026 637.50K $9.52M Hold
Q3 2026 641.50K $7.39M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRVS and 13F data

CRVS (CORVUS PHARMACEUTICALS INC) is a Health Care company. 66 other funds we track also report a position in CRVS — the largest reported positions include ORBIMED ADVISORS LLC (US$107.0M), ADAMS STREET PARTNERS LLC (US$48.9M), PERCEPTIVE ADVISORS LLC (US$39.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRVS

All CRVS fund holders →

FAQ

How long has DCF Advisers, LLC held CRVS?

DCF Advisers, LLC has disclosed CRVS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is DCF Advisers, LLC's current position in CRVS?

As of Q3 2026, DCF Advisers, LLC holds 641.50K shares of CRVS (CORVUS PHARMACEUTICALS INC), valued at $7.39M, representing 2.18% of its reported portfolio and ranking #11.

Has DCF Advisers, LLC been buying or selling CRVS?

In the latest 13F filing (Q3 2026), DCF Advisers, LLC increased its position in CRVS. The position peaked in Q2 2026 at 637.50K shares.

Which other funds hold CRVS?

Other major institutional holders of CRVS include ORBIMED ADVISORS LLC, ADAMS STREET PARTNERS LLC, PERCEPTIVE ADVISORS LLC, among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.